In the Huntington’s disease model, activation of TRPC5 through glutathionylation has also been shown to cause the loss of striatal neurons (Hong et al., 2015), and this effect can be mitigated through destabilizing the presence of TRPC5 on plasma membrane via depalmitoylation (Hong et al., 2020). This evidence concerns the gene TRPC5 and Huntington disease.